The Valley Desk

NCT00783367 · Interventional trial

Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas

Overall registry status Completed

Phase 2

Conditions Follicular Lymphoma, Lymphoma of Mucosa-Associated Lymphoid Tissue, Lymphoma, Small Lymphocytic, MALT Lymphoma, Mantle-Cell Lymphoma, Marginal Zone B-Cell Lymphoma, Waldenstrom Macroglobulinemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov